Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot O95870: Variant p.Arg457Gln

Phosphatidylserine lipase ABHD16A
Gene: ABHD16A
Feedback?
Variant information Variant position: help 457 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Arginine (R) to Glutamine (Q) at position 457 (R457Q, p.Arg457Gln). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and polar (Q) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In SPG86; no protein detected in homozygous patient cells; increased levels of phosphatidylserine and decreased levels of lysophosphatidylserine in homozygous patient cells, indicating loss of function in phosphatidylserine catabolism. Any additional useful information about the variant.


Sequence information Variant position: help 457 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 558 The length of the canonical sequence.
Location on the sequence: help VPEDIMSNRGNDLLLKLLQH R YPRVMAEEGLRVVRQWLEAS The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         VPEDIMSNRGNDLLLKLLQHRYPRVMAEEGLRVVRQWLEAS

Mouse                         VPEDIMSNRGNDLLLKLLQFRYPRVMVEEGLRAVRQWLEAS

Rat                           VPEDIMSNRGNDLLLKLLQFRYPRVMTEEGLRAVRQWLEAS

Bovine                        VPEDIMSNRGNDLLLKFLQHRYPRVMAEEGLRVVRQWLEAS

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 558 Phosphatidylserine lipase ABHD16A
Topological domain 114 – 558 Cytoplasmic



Literature citations
Pathogenic variants in ABHD16A cause a novel psychomotor developmental disorder with spastic paraplegia.
Yahia A.; Elsayed L.E.O.; Valter R.; Hamed A.A.A.; Mohammed I.N.; Elseed M.A.; Salih M.A.; Esteves T.; Auger N.; Abubaker R.; Koko M.; Abozar F.; Malik H.; Adil R.; Emad S.; Musallam M.A.; Idris R.; Eltazi I.Z.M.; Babai A.; Ahmed E.A.A.; Abd Allah A.S.I.; Mairey M.; Ahmed A.K.M.A.; Elbashir M.I.; Brice A.; Ibrahim M.E.; Ahmed A.E.; Lamari F.; Stevanin G.;
Front. Neurol. 12:720201-720201(2021)
Cited for: VARIANTS SPG86 114-ARG--LEU-558 DEL AND GLN-457; CHARACTERIZATION OF VARIANTS SPG86 114-ARG--LEU-558 DEL AND GLN-457; INVOLVEMENT IN SPG86;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.